Gateway Announces News on Lactoferrin; Lactoferrin Fights NSAID Side Effects.

LAS VEGAS -- Stock symbol should read: OTCBB: GWDB (sted OTCBB:GAWD)

The corrected release reads:

GATEWAY ANNOUNCES NEWS ON LACTOFERRIN; LACTOFERRIN FIGHTS NSAID SIDE EFFECTS

Gateway (OTCBB:GWDB)

The number of people taking NSAIDs (nonsteroidal anti-inflammatory drugs, such as aspirin, Ibuprofin, etc.) increases every year, but concern about ulcer complications and intestinal bleeding may be decreased with the use of lactoferrin. At least 3 billion dollars are spent on oral analgesics, with about 60 percent of these including NSAIDs. Seventy percent of people over 65 take one dose of NSAIDs every week, and 50 percent take seven doses a week!

The biggest risk factor is a history of a complicated ulcer. Other risk factors for NSAID-associated ulcer complications include:

--Aspirin

--Taking multiple NSAIDs

--High-dose NSAIDs

--Anticoagulants

--Past history of uncomplicated ulcer

--Being older than 70

--Taking steroids

The good news is that orally administered lactoferrin is effective at preventing acute NSAID-induced increases in gut bleeding and other negative metabolic activity. Protection by lactoferrin of the intestinal tract from NSAIDs appears to be linked to the lessening of the migration of certain cells to the intestine. The lactoferrin does not bind to the NSAID or interfere with the NSAID biological activity.

Researchers conclude that orally administered lactoferrin is effective at preventing NSAID-induced intestinal problems, which is very good news to those who look to NSAIDs for pain relief from arthritis, among other health challenges.

Source: Journal of Pharmacy & Pharmacology 2005; 57(1):93-9.

The principal activity of Gateway Distributors Limited, headquartered in Las Vegas, Nevada, is to distribute whole food nutrition, health and dietary supplements and skin care products. The Group has been in business since 1993 and markets and distributes eighteen different nutritional and health products under the trademark of the Right Solution and nine Jeunesse by Francois skin care products. Currently, the Company sells its products primarily in the USA, Canada and Japan. Information related to the Company's products and opportunity can be found on the website at www.rightsolution.com.

A number of statements contained in this press release are forward-looking statements, which are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995.

These forward-looking statements involve a number of risks and uncertainties, including the timely development, and market acceptance conditions, successful integration of acquisitions and the ability to secure additional sources of financing. The actual results that GTWY may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.